Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2006
05/24/2006EP1658850A1 The use of mirtazapine for the treatment of sleep disorders
05/24/2006EP1658290A2 Compounds and compositions as protein kinase inhibitors
05/24/2006EP1658289A2 3-substituted imidazopyridine-derivatives as c-kit inhibitors
05/24/2006EP1658282A1 Novel chelating agents and chelates and their use
05/24/2006EP1658264A2 Methods and compositions for treating amyloid-related diseases
05/24/2006EP1658076A1 Aryloxy and arylalkyleneoxy substituted imidazoquinolines
05/24/2006EP1474425B1 Deazapurines and uses thereof
05/24/2006EP1334106B1 Imidazole derivatives, production method thereof and use thereof
05/24/2006EP1325002B1 1,2,5,10-tetrahydropyridazino¬4,5-b|quinoline-1,10-diones and their use for the treatment of pain
05/24/2006EP1320529B1 Quinoline derivatives as antibacterials
05/24/2006EP1259520B1 Novel purines
05/24/2006EP1019058B1 Pharmaceutical suspension comprising nevirapine hemihydrate
05/24/2006CN1777663A Organic electroluminescent devices and metal complex compounds
05/24/2006CN1777605A Cannabined receptor ligands and uses thereof
05/24/2006CN1777604A Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives
05/24/2006CN1777603A Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
05/24/2006CN1777602A Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
05/24/2006CN1257169C Bicyclic imidazo-3-yl-amine derivatives
05/24/2006CN1257168C Compound of pyrazole [4,3-c] quinolines and preparation process thereof
05/24/2006CN1257158C N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity
05/23/2006US7049443 Such as 2-(3-(Acetyl(((5S)-3-(4-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-3 -fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)meth yl)amino)-1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl dihydrogen phosphate; improved bioavailability
05/23/2006US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents
05/23/2006US7049374 Heterodiamondoids
05/23/2006US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor
05/23/2006US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis
05/23/2006US7049315 Solubilized topoisomerase poisons
05/23/2006US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity
05/23/2006US7049310 Therapy for bacteria infections
05/23/2006US7048909 Aerosols containing nondegraded atenolol, pindolol, esmolol, propranolol, or metoprolol
05/23/2006CA2411766C Non-nucleoside reverse transcriptase inhibitors
05/23/2006CA2339630C Carboline derivatives as cgmp phosphodiesterase inhibitors
05/23/2006CA2257200C Substituted imidazoles having cytokine inhibitory activity
05/23/2006CA2199599C Incorporation of aromatic polycyclic compounds in quinacridone processes
05/23/2006CA2199597C Incorporation of pigment derivatives in quinacridone processes
05/18/2006WO2006052962A2 Bicyclic triazole a4 integrin inhibitors
05/18/2006WO2006052886A1 Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof
05/18/2006WO2006051757A1 Remedy or preventive for ischemic cardiac disease or ischemic cardiac myopathy
05/18/2006WO2006051704A1 Imine compound
05/18/2006WO2006050976A1 Azaindole carboxamides
05/18/2006WO2006050800A1 4-amino-5-oxo-8-phenyl-5h-pyrido-[2,3-d]-pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours
05/18/2006WO2006050779A1 N,n'-diphenyl urea derivatives suitable as kinase inhibitors
05/18/2006WO2006018184A3 Spirocyclic cyclohexane derivatives
05/18/2006WO2006012504A3 Compounds and methods for treatment of thrombosis
05/18/2006WO2005121151A3 Thienopyridinone compounds and methods of treatment
05/18/2006WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof
05/18/2006WO2005032484A9 Alkoxy substituted imidazoquinolines
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/18/2006US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof
05/18/2006US20060106061 PGD2 receptor antagonists for the treatment of inflammatory diseases
05/18/2006US20060106052 Method of using sulfonamide substituted imidazoquinolines
05/18/2006US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders
05/18/2006US20060106045 Spiroindolinepiperidine derivatives
05/18/2006US20060106034 Drug efflux pump inhibitor
05/18/2006US20060106033 Pyrazolopyridines and methods of making and using the same
05/18/2006US20060106020 Tetracyclic inhibitors of Janus kinases
05/18/2006US20060106008 Pharmaceutical use of fused 1,2,4-triazoles
05/18/2006US20060106007 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide
05/18/2006US20060106006 Including vanadocene dihalides, bis(methylcyclopentadienyl), vanadocene diazide, vanadocene dicyanide, vanadocene dioxycyanate, vanadocene dithiocyanate, vanadocene diselenocyanate, vanadocene ditriflate, vanadocene monochloro oxycyanate, vanadocene monochloro acetonitrilo tetrachloro ferrate
05/18/2006US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
05/18/2006DE102004054634A1 Azaindolcarboxamide Azaindolcarboxamide
05/18/2006CA2591474A1 Therapeutic or preventive agents for ischemic heart disease or ischemic cardiomyopathy
05/18/2006CA2587667A1 Imine compound
05/18/2006CA2587609A1 4-amino-5-oxo-8-phenyl-5h-pyrido[2,3-d]pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours
05/18/2006CA2586929A1 N,n'-diphenylurea derivatives suitable as kinase inhibitors
05/18/2006CA2586623A1 Process for preparing quinoline compounds and products obtained therefrom
05/18/2006CA2586122A1 Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof
05/18/2006CA2585315A1 Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto
05/18/2006CA2575668A1 Azaindole carboxamides
05/17/2006EP1657242A1 Imidazopyridine derivatives
05/17/2006EP1656940A1 Angiotensin II receptor antagonists for treating vascular headache conditions
05/17/2006EP1656937A1 The use of mirtazapine for the treatment of sleep disorders
05/17/2006EP1656377A1 Aminobenzimidazole derivatives
05/17/2006EP1656376A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
05/17/2006EP1656373A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists
05/17/2006EP1656365A1 A method for the preparation of enantiomerically pure mirtazapine
05/17/2006EP1656353A1 Gabanergic modulators
05/17/2006EP1656349A1 Cyclopropyl derivatives as nk3 receptor antagonists
05/17/2006EP1656140A1 Mitotic kinesin inhibitors
05/17/2006EP1551902A4 Anisotropic films based on 1,8-naphthoylene-1 ,2 -benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making
05/17/2006EP1543003B1 Imidazo¬1,2-a|pyridines
05/17/2006EP1432712B1 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
05/17/2006EP1377552B1 Metal complexes and therapeutic uses thereof
05/17/2006EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1337533B1 Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine
05/17/2006EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1274711B1 New aza-indolyl derivatives
05/17/2006EP0937077B1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
05/17/2006CN1774490A 有机电致发光装置和铂化合物 Organic electroluminescent devices and platinum compounds
05/17/2006CN1774437A 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands
05/17/2006CN1774250A (6-(phenoxy)-pyrido[3,4-d) pyrimidin-2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatoryy conditions such as rheumatois artritis
05/17/2006CN1774247A Novel compounds
05/17/2006CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
05/16/2006US7045529 Imidazopyrimidinyl and imidazopyri dinyl derivatives
05/16/2006US7045527 Piperidine derivatives
05/16/2006US7045118 Delivery of compounds for the treatment of migraine through an inhalation route
05/16/2006CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors